Let's focus on what we can do!

By Disabled People for Disabled People

  • Home
  • >
  • Chronic Fatigue Syndrome me/cfs
  • >
  • Clinical trial provides preliminary evidence of a cure for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Long Covid – PR Newswire
Monday, 6 September, 2021

Clinical trial provides preliminary evidence of a cure for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Long Covid – PR Newswire

Limbic System

 
Cortene Inc. announces publication of its InTiME clinical trial in which a short subcutaneous infusion of its experimental drug, CT38, achieved sustained symptom improvement in ME/CFS. The company intends to test CT38 in Long Covid, the post-acute stage of COVID-19 infection, which is considered by many to be the latest trigger for ME/CFS.

Cortene believes the CRFR2 pathway is upregulated and therefore overactive, leading to the wide variety of symptoms in ME/CFS. “The conventional approach would be to block the overactive pathway,” said Sanjay Chanda, PhD, Cortene’s Chief Development Officer. “Instead, our counterintuitive approach seeks to overstimulate CRFR2, causing it to downregulate, without the need for chronic treatment.”

Read more at: https://www.prnewswire.co.uk/news-releases/clinical-trial-provides-preliminary-evidence-of-a-cure-for-myalgic-encephalomyelitis-chronic-fatigue-syndrome-me-cfs-and-long-covid-876403518.html

Categories :
  • Chronic Fatigue Syndrome me/cfs
  • Latest Headlines
  • Myalgic Encephalomyelitis ME/CFS
Socials :

Recent posts

Student Profiles Coming Soon...